Eli Lilly's Antibody Reduces COVID-19 Risk by 80% in Nursing Homes
- Oops!Something went wrong.Please try again later.
Results of a clinical trial suggest pre-emptive treatment with bamlanivimab can prevent COVID-19 from spreading through nursing homes.